Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insights

Set Alert for Digital Health

Minute Insight: Abbott Teams Up With WeightWatchers In Diabetes Management

The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.

Minute Insights Diabetic Care

Minute Insight: NeuroOne Amends Deal With Zimmer Biomet To Shore Up Balance Sheet

Zimmer Biomet agreed to amend its exclusive development and distribution agreement with NeuroOne to pay $3.5m for 350,000 of stock. The deal will help NeuroOne continue to develop its Evo stereoelectroencephalography brain-mapping electrodes without further diluting the company’s stock.

Minute Insights Neurology

Minute Insight: Novartis, Medtronic, NHS Trust And RYSE Join Forces To Spur Development Of Digital Heart Health Solutions

Novartis Biome UK Heart Health Catalyst is taking applications from start-ups, researchers and technologists through 31 August. As much as £3m is up for grabs and specific interest in non-invasive lipid measurement techniques and at-home blood pressure testing using software as a medical device.

Minute Insights Deals

Minute Insight: Acutus Adds Another Device To The Left-Heart Business It Sold To Medtronic

The company announced the US launch of the AcQCross Qx transseptal dilator/needle. It is specifically designed to help deploy Boston Scientific’s Watchman left-atrial appendage closure device, but it is part of the left-heart access device portfolio that Acutus recently sold to Medtronic.

Minute Insights Launches

Minute Insight: Abbott Plans Move Into Famous Chicago Skyscraper

Local newspapers in Chicago confirm that Abbott is leasing space in Chicago’s most famous building in an attempt to better serve employees who live closer to the city than its Lake County, IL, campus.

Minute Insights Business Strategies

Minute Insight: Abbott Is Planning To Combine Glucose And Ketone Measurement Into One Wearable

The company announced that it is developing a new biowearable device that will continuously monitor both glucose and ketone levels with one sensor.

Minute Insights Diabetic Care

Minute Insight: Abbott Touts 14-Day FreeStyle Libre 3 Data

Shortly after the FDA approved Abbott's FreeStyle Libre 3 continuous glucose monitor system, the company announced new clinical data showing that it is the most accurate 14-day CGM system available.

Minute Insights Diabetic Care

Minute Insight: Real-World Data Supports Medtronic’s 780G Insulin Pump

Postmarket data from Europe and Chile, announced at the American Diabetes Association conference, offer more support for Medtronic’s faith in its MiniMed 780G system with the Guardian 4 sensor.

Minute Insights Clinical Trials
See All
UsernamePublicRestriction

Register